Partnership agreement between MARS and VIRALL aims to promote innovative Nanotechnology and Artificial Intelligence projects for medical applications.

MARS-Medical Agency for Research and Statistics and Venture Innovation Reaching ALL (VIRALL) have signed a collaboration agreement to consult clinical researchers across the Middle East and North Africa.

“We are optimistic that this partnership will result in excellent outcomes in innovative products and startups,” said Dr. Shara (Co-founder and CEO of VIRALL). “This partnership with MARS will focus on innovative projects utilizing AI and Nano technology in Health Care."

The partnership is also intended to support innovative projects and solutions to the medical research community by improving the Artificial Intelligence and Nanotechnology in health care, funding for new researchers and guide them with innovative ideas.

“We're delighted to partner with VIRALL and support its vital mission and consulting work for innovative researchers across the Middle East and North Africa," said Nouran Hamza, Founder and CEO of MARS.” “Together we will support innovative solutions and entrepreneurship development throughout the medical research community by improving their Artificial Intelligence and Nanotechnology solutions for the benefit of the world.”

Learn more about MARS and VIRALL.